Publisher Summary This chapter elaborates the cholinergic–dopaminergic relation in different brain structures. Neostriatal neurons respond in an opposite manner to the iontophoretic application of dopaminergic and cholinergic compounds and to their respective antagonists. Thus, dopamine (DA) depresses, whereas acetylcholine (ACh) or physostigmine enhance the firing rate of caudate cells. A direct approach to the problem of the interconnection and the mutual regulation of striatal DA and ACh systems is provided by the measurement of drug-induced changes in the amounts of transmitters continuously released within the striatum. It is found that a striatal cholinergic system may be under a regulatory dopaminergic influence. It is possible that the nigro-striatal DA pathway modulates the activity and function of some cholinergic neurons by a tonic inhibitory input. It is found that impairment of dopaminergic transmission would result in an increased activity of cholinergic neurons, ACh release, and in the appearance of Parkinsonian symptoms. This is supported by the observations that anticholinergic drugs ameliorate rigidity, and tremor in Parkinson's disease, and extrapyramidal dysfunction caused by neuroleptic compounds.
Read full abstract